Abordaje integral del paciente con diabetes mellitus tipo 2 y enfermedad cardiovascular o de muy alto riesgo cardiovascular-Reference-Cited by-同舟云学术

Abordaje integral del paciente con diabetes mellitus tipo 2 y enfermedad cardiovascular o de muy alto riesgo cardiovascular

Published:2019-07 Issue:3 Volume:54 Page:183-192
ISSN:2605-1532
Container-title:REC: CardioClinics
language:es
Short-container-title:REC: CardioClinics

Author:

Castro Conde Almudena,Marzal Martín Domingo,Arrarte Vicente,Campuzano Raquel,Dalmau González-Gallarza Regina,Fernández Olmo M. Rosa,García-Moll Xavi,Gómez Doblas Juan José,Gorgojo Juan José,Mazón Pilar,Morillas Ariño Carlos,Obaya Juan Carlos,Soler M. José,Gorriz Teruel José Luis

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference42 articles.

1. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N Engl J Med,2015

2. Empagliflozin and progression of kidney disease in type 2 diabetes;Wanner;N Engl J Med,2016

3. Liraglutide and cardiovascular outcomes in type 2 diabetes;Marso;N Engl J Med,2016

4. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes;Marso;N Engl J Med,2016

5. Canagliflozin and cardiovascular and renal events in type 2 diabetes;Neal;N Engl J Med,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expert Consensus on the Management of Adverse Events of Lorlatinib in the Treatment of ALK+ Advanced Non-small Cell Lung Cancer;Clinical Drug Investigation;2024-07-31

2. Multidisciplinary Panel Consensus for the Management of Patients with Type 2 Diabetes: A Delphi Study;Archives of Medical Research;2024-01

3. Comprehensive Cardiovascular and Renal Protection in Patients with Type 2 Diabetes;Journal of Clinical Medicine;2023-06-08

4. Selección de lo mejor de 2020 en riesgo vascular y rehabilitación cardiaca;REC: CardioClinics;2021-01

5. Comentarios a la guía ESC 2019 sobre diabetes, prediabetes y enfermedad cardiovascular;Revista Española de Cardiología;2020-05